Created at 1:27 a.m. Dec, 02, 2025
Bulk Suggestion Bulk ID: mbaroody/12.02.25-01:27AM
Author: mbaroody
Related Note: 1484768435794 1
Rationale for change

This is a crucial piece of information that would have helped distinguish between two answers on UWorld question id: 1443.

The question requires us to know that benzos increase the frequency (Choice C) versus duration (Choice B) of chloride channel opening. It would also be important to know that barbiturates have the opposite mechanism of action as well if you were inclined to pick Choice C.

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#SketchyPharm::09_Pharmacology_Foundations::06_Pharmacodynamic_Basics::01_Agonists,_Antagonists_&_Allosteric_Modulators #AK_Step1_v12::#B&B::16_Neuro::01_Introduction_to_Neurology::04_Neurotransmitters #AK_Step1_v12::#Physeo::09_Pharm::14_Neuro::05_Benzodiazepines #AK_Step1_v12::#AMBOSS::#Self_Assessment #AK_Step1_v12::#B&B::16_Neuro::05_Other_Neurology_Topics::16_Sleep_Physiology::Extra #AK_Step2_v12::#AMBOSS::GnaBuO #AK_Step1_v12::#FirstAid::12_Neurology_and_Special_Senses::06_Pharm::03_Benzodiazepines #AK_Step1_v12::#Bootcamp::Psychiatry::08_Substance_Misuse::05_Benzodiazepines #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::01_Drugs_for_Epilepsy #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#UWorld::Step::937 #AK_Step1_v12::#Physeo::^physeo_image_update #PANCE::BEHAVIORAL::substance_use #AK_Step1_v12::#Bootcamp::Neurology::25_Neurotransmitter_Activity_in_Psychiatric_Disease::02_Acetylcholine,_Dopamine,_Norepinephrine,_Serotonin,_and_GABA #AK_Step1_v12::#UWorld::COMLEX::24554 #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::02_Anxiolytic_and_Hypnotic_Drugs #AK_Step1_v12::#AMBOSS::GnaBuO #AK_Other::Only_Step_1 #AK_Step1_v12::#NinjaNerd::12_Neurology::03_Pathology::10_Febrile_Seizures_(Etiology,_Pathophysiology,_Clinical_Features,_Treatment) #AK_Step1_v12::#Bootcamp::Neurology::28_Seizures::05_Status_Epilepticus #AK_Step1_v12::#UWorld::Step::1443 #AK_Step1_v12::#Bootcamp::Neurology::28_Seizures::06_Antiepileptic_Medications #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step1_v12::#Bootcamp::Neurology::11_Conduction_Physiology::04_Ion_Channel_Inhibitors_and_Activators #AK_Step1_v12::#NBME::Free120 #AK_Step1_v12::^Systems::Neuro::Pharmacology #AK_Step1_v12::#UWorld::Step::11665 #AK_Step1_v12::#OME::Clinical::04_Organ_Systems::08_Neuroscience::03_Clincial_Cortex::02_GABA_Receptors_and_Alcohol #AK_Step2_v12::#SketchyPsych::10_Substance_Use/_Medication_Related_Disorders::01_Substance_Use_Overview #AK_Step1_v12::#B&B::16_Neuro::05_Other_Neurology_Topics::10_Multiple_Sclerosis::Extra #PANCE::EOR::PSYCH #AK_Step1_v12::#NinjaNerd::12_Neurology::03_Pathology::09_Seizures_(Etiology,_Pathophysiology,_Clinical_Features,_Treatment,_Complications/Status_Epilepticus #AK_Step1_v12::#OME::04_Organ_Systems::08_Neuroscience::03_Clincial_Cortex::02_GABA_Receptors_and_Alcohol #AK_Step1_v12::#Pixorize::03_Pharmacology::16_Other_Neuro_Pharm::03_Benzodiazepines-Function #AK_Step1_v12::#AMBOSS::Bjazck #AK_Step1_v12::#B&B::16_Neuro::05_Other_Neurology_Topics::05_Anticonvulsants_II #AK_Step2_v12::#CMS::Psychiatry::Form_7 #AK_Step1_v12::#UWorld::COMLEX::24049 #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::06_Sedative-Hypnotics::01_Benzodiazepines_&_Flumazenil #AK_Step1_v12::#AMBOSS::g6aF4l